AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32571429 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART initiation (≤14 days after PCP diagnosis)
Number of subjects: 200
Study 32571429 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation (>14 days after PCP diagnosis)
Number of subjects: 200
Study 34986285 — intervention group
Group type: EXPERIMENTAL
Intervention: Relatlimab and Nivolumab
Number of subjects: 0
Study 34986285 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab
Number of subjects: 0
Study 34587963 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthobox application (case group)
Number of subjects: 120
Study 34587963 — intervention group
Group type: COMPARATOR
Intervention: No access to Orthobox application (control group)
Number of subjects: 120
Study 32648835 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed preoperative patient education and counselling about the mode of anaesthesia, extubation process, and expected response at extubation.
Number of subjects: 100
Study 32648835 — intervention group
Group type: COMPARATOR
Intervention: Routine counselling (control group).
Number of subjects: 100
Study 32648835 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed preoperative patient education and counselling.
Number of subjects: 100
Study 33494832 — intervention group
Group type: EXPERIMENTAL
Intervention: active tDCS (0.8 A/m2)
Number of subjects: 12
Study 33494832 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 12
Study 34896904 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (three capsules, twice/day)
Number of subjects: 159
Study 34896904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 33055456 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular protrusion
Number of subjects: 186
Study 33055456 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth protrusion
Number of subjects: 186
Study 33055456 — intervention group
Group type: EXPERIMENTAL
Intervention: Disrupted fibrous tissue protrusion
Number of subjects: 186
Study 35891492 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodynamic evaluation
Number of subjects: 40
Study 35891492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation
Number of subjects: 40
Study 35891492 — intervention group
Group type: COMPARATOR
Intervention: Cystographic evaluation
Number of subjects: 40
Study 35891492 — intervention group
Group type: COMPARATOR
Intervention: Scintigraphic evaluation
Number of subjects: 40
Study 35891492 — intervention group
Group type: EXPERIMENTAL
Intervention: Postvoid residual volume assessment
Number of subjects: 40
Study 35891492 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of febrile urinary tract infection
Number of subjects: 40
Study 35891492 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of intestinal constipation
Number of subjects: 40
Study 34496941 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical decompression and fusion (ACDF)
Number of subjects: 110
Study 34496941 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior foraminotomy (PF)
Number of subjects: 110
Study 32643886 — intervention group
Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion combined with electroacupuncture
Number of subjects: 72
Study 32643886 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium double-release enteric-coated capsules and Fugui Gutong capsules
Number of subjects: 72
Study 35246620 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS with upper extremity rehabilitation
Number of subjects: 44
Study 35246620 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with upper extremity rehabilitation
Number of subjects: 44
Study 32487567 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 0
Study 32487567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35537121 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 28
Study 35537121 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 28
Study 32450720 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscotrabeculotomy
Number of subjects: 92
Study 32450720 — intervention group
Group type: COMPARATOR
Intervention: Conventional trabeculotomy
Number of subjects: 92
Study 33010112 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg orally twice daily)
Number of subjects: 19
Study 32488238 — intervention group
Group type: EXPERIMENTAL
Intervention: TrP dry needling
Number of subjects: 19
Study 32488238 — intervention group
Group type: COMPARATOR
Intervention: non-TrP dry needling
Number of subjects: 19
Study 35263862 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 40
Study 35263862 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine hemodynamic monitoring)
Number of subjects: 40
Study 33536156 — intervention group
Group type: COMPARATOR
Intervention: Live bedside music performed by professional musicians, once a day for six or seven consecutive days
Number of subjects: 0
Study 32684500 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-aid (DA) tool
Number of subjects: 3547
Study 32684500 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DA tool)
Number of subjects: 3547
Study 36049050 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiome L-tryptophan biosynthesis during acute COVID-19
Number of subjects: 52
Study 36049050 — intervention group
Group type: COMPARATOR
Intervention: Plasma 5-HT concentration at the time of COVID-19
Number of subjects: 52
Study 33814432 — intervention group
Group type: EXPERIMENTAL
Intervention: Global cognition and cognitive domain function
Number of subjects: 309
Study 33814432 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial ability and EF (verbal fluency)
Number of subjects: 309
Study 36167574 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia with propofol
Number of subjects: 344
Study 36167574 — intervention group
Group type: COMPARATOR
Intervention: Inhalation anesthesia with sevoflurane
Number of subjects: 344
Study 32712226 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI genetic risk scores (hpGRS)
Number of subjects: 0
Study 32712226 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI genetic risk scores (sGRS)
Number of subjects: 0
Study 32712226 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI and hpGRS
Number of subjects: 0
Study 32097899 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning-based tumor tracking system
Number of subjects: 8
Study 35150590 — intervention group
Group type: COMPARATOR
Intervention: 0.25% sodium hypochlorite (positive control)
Number of subjects: 108
Study 35150590 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% Triclosan
Number of subjects: 108
Study 35150590 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture disinfecting tablets
Number of subjects: 108
Study 35150590 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture disinfecting tablets plus palatine mucosa brushing solution
Number of subjects: 108
Study 35150590 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 108
Study 32448992 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat soya blend plus (WSBP) provided during pregnancy and lactation (5 kg/month, 165 g/day)
Number of subjects: 2030
Study 32448992 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat soya blend plus (WSBP)
Number of subjects: 2030
Study 32827193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (topical corticosteroids + antibiotics)
Number of subjects: 59
Study 32827193 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroids treatment
Number of subjects: 59
Study 35090987 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 87
Study 35090987 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol
Number of subjects: 87
Study 34369693 — intervention group
Group type: EXPERIMENTAL
Intervention: Huayu Tongluo moxibustion combined with acupuncture at Jing‐well points on the differentiated meridians and routine acupuncture
Number of subjects: 60
Study 34369693 — intervention group
Group type: COMPARATOR
Intervention: Donepezil, 5 mg once a day for 4 weeks
Number of subjects: 60
Study 35191202 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 248
Study 35191202 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 248
Study 35191202 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 248
Study 33907785 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin‐block appliance combined with straight wire appliance
Number of subjects: 60
Study 33907785 — intervention group
Group type: COMPARATOR
Intervention: Straight wire appliance
Number of subjects: 60
Study 33907888 — intervention group
Group type: EXPERIMENTAL
Intervention: Kahook Dual Blade ab interno trabeculectomy combined with phacoemulsification
Number of subjects: 33
Study 33907888 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 33
Study 32592571 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave therapy (SVT) + transcerebral magnetotherapy
Number of subjects: 40
Study 32592571 — intervention group
Group type: COMPARATOR
Intervention: Shock wave therapy (SVT)
Number of subjects: 40
Study 35320317 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe pneumonia (cases)
Number of subjects: 2597
Study 35320317 — intervention group
Group type: COMPARATOR
Intervention: Pneumonia (controls)
Number of subjects: 2597
Study 32914509 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioglass-containing desensitising toothpaste
Number of subjects: 61
Study 32914509 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma desensitiser
Number of subjects: 61
Study 32914509 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronal pulpotomy using Biodentine
Number of subjects: 61
Study 34976102 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral Direct Anterior Approach (L-DAA)
Number of subjects: 24
Study 34976102 — intervention group
Group type: COMPARATOR
Intervention: Traditional Posterolateral Approach (PLA)
Number of subjects: 24
Study 33067484 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning classifiers using multiparametric MRI sequences (axial T1WI, T2WI, CE-T1WI, ADC maps)
Number of subjects: 60
Study 33067484 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of all MRI sequences excluding ADC map
Number of subjects: 60
Study 33140215 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA
Number of subjects: 45
Study 33140215 — intervention group
Group type: EXPERIMENTAL
Intervention: amisulpride
Number of subjects: 45
Study 33140215 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study 32545250 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation of 400 IU/day
Number of subjects: 195
Study 32545250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 35472660 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle strength training (IMST) at 50% of maximal inspiratory pressure (MIP) for 7 days/8 weeks
Number of subjects: 32
Study 35472660 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle endurance training (IMET) at 30% of MIP for 7 days/8 weeks
Number of subjects: 32
Study 35472660 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as the comparison between IMST and IMET)
Number of subjects: 32
Study 33848836 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartate transaminase and/or alanine transaminase ratio (DRR)
Number of subjects: 183
Study 33848836 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) curve analysis of DRR
Number of subjects: 183
Study 33848836 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratification by optimal DRR cutoff value of 1.29
Number of subjects: 183
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group using high-definition (HD) white-light endoscopy
Number of subjects: 25304
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group with primary colonoscopy screening (12 RCTs)
Number of subjects: 25304
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group with FIT as an indication for colonoscopy
Number of subjects: 25304
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group with age as a factor
Number of subjects: 25304
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group with sex as a factor
Number of subjects: 25304
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group with withdrawal time as a factor
Number of subjects: 25304
Study 36243103 — intervention group
Group type: COMPARATOR
Intervention: Control group with methodological factors
Number of subjects: 25304
Study 33385694 — intervention group
Group type: EXPERIMENTAL
Intervention: DOMS (eccentric exercise)
Number of subjects: 53
Study 33385694 — intervention group
Group type: COMPARATOR
Intervention: Sham condition (concentric exercise)
Number of subjects: 53
Study 32671536 — intervention group
Group type: COMPARATOR
Intervention: Long tube (LT)
Number of subjects: 223
Study 32671536 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tube with Gastrografin (NGT-G)
Number of subjects: 223
Study 32671536 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric tube alone (NGT)
Number of subjects: 223
Study 35843782 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic education intervention using medical imaging visualization with the software 'Stone of Orthanc'
Number of subjects: 49
Study 35843782 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study 35843782 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic education intervention
Number of subjects: 49
Study 35843782 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study 32871100 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 251
Study 32871100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 36264607 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based stress management intervention (SMI)
Number of subjects: 262
Study 36264607 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 262
Study 35399847 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-in-one optimized emergency nursing procedure
Number of subjects: 78
Study 35399847 — intervention group
Group type: COMPARATOR
Intervention: Routine emergency care (Control)
Number of subjects: 78
Study 34024137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group I (prompting)
Number of subjects: 141
Study 34024137 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 141
Study 34024137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group II (not specified)
Number of subjects: 141
Study 32827953 — intervention group
Group type: EXPERIMENTAL
Intervention: Strap intermuscular approach
Number of subjects: 104
Study 32827953 — intervention group
Group type: COMPARATOR
Intervention: Traditional approach
Number of subjects: 104
Study 34311004 — intervention group
Group type: EXPERIMENTAL
Intervention: Target volume delineation informed by 1F-FDG PET and CT plus elective nodal irradiation (arm A)
Number of subjects: 205
Study 34311004 — intervention group
Group type: COMPARATOR
Intervention: Target volumes informed by PET alone (arm B)
Number of subjects: 205
Study 32445474 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum oral azithromycin
Number of subjects: 0
Study 32445474 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 32512963 — intervention group
Group type: EXPERIMENTAL
Intervention: AHH group (6% hydroxyethyl starch 130/0.4 at a rate of 20 ml/min after anesthesia induction)
Number of subjects: 80
Study 32512963 — intervention group
Group type: COMPARATOR
Intervention: C group (no AHH)
Number of subjects: 80
Study 35988587 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 genotype-guided antithrombotic treatment (clopidogrel 75 mg for normal metabolizers, clopidogrel 150 mg for intermediate metabolizers, acetylsalicylic acid 80 mg plus rivaroxaban 2.5 mg for poor metabolizers)
Number of subjects: 2276
Study 35988587 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily (control group)
Number of subjects: 2276
Study 35988587 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 genotype-guided antithrombotic treatment
Number of subjects: 2276
Study 34157755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use for treating IBD
Number of subjects: 417
Study 34157755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use for recreational purposes
Number of subjects: 417
Study 34157755 — intervention group
Group type: COMPARATOR
Intervention: Non-users of cannabis
Number of subjects: 417
Study 36281107 — intervention group
Group type: EXPERIMENTAL
Intervention: ILIB (intravascular laser irradiation of blood) with 2 sessions of 20 minutes for 12 weeks
Number of subjects: 45
Study 36281107 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser application with 2 sessions of 20 minutes for 12 weeks
Number of subjects: 45
Study 36281107 — intervention group
Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 45
Study 32807627 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial attitudes toward legalization of AR‐EAS
Number of subjects: 1711
Study 32807627 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing one of six randomly assigned scenarios depicting an ethical or practical issue in AR‐EAS
Number of subjects: 1711
Study 32807627 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for AR‐EAS legalization after reading specific scenarios
Number of subjects: 1711
Study 35379380 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic amoxicillin‐clavulanic acid (0.375 mg/mL) for 14 days
Number of subjects: 2
Study 35379380 — intervention group
Group type: COMPARATOR
Intervention: Untreated drinking water (Control)
Number of subjects: 2
Study 35379380 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of C. bovis inoculation and oral antibiotics (Cb+Abx+)
Number of subjects: 2
Study 32868370 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunity
Number of subjects: 1204
Study 32868370 — intervention group
Group type: COMPARATOR
Intervention: Antibody
Number of subjects: 1204
Study 32868370 — intervention group
Group type: EXPERIMENTAL
Intervention: Passport
Number of subjects: 1204
Study 32868370 — intervention group
Group type: EXPERIMENTAL
Intervention: Certificate
Number of subjects: 1204
Study 32868370 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceiving no risk of infection
Number of subjects: 1204
Study 34431001 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTG + EDTA
Number of subjects: 20
Study 34431001 — intervention group
Group type: COMPARATOR
Intervention: SCTG
Number of subjects: 20
Study 34050362 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratch (ES) procedure
Number of subjects: 1048
Study 34050362 — intervention group
Group type: COMPARATOR
Intervention: TAU (no endometrial scratch)
Number of subjects: 1048
Study 32199016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic exposure (IHE) combined with sports training (n=6)
Number of subjects: 12
Study 32199016 — intervention group
Group type: COMPARATOR
Intervention: Control group (sports training only, n=6)
Number of subjects: 12
Study 36045948 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge combined internal fixation system (BCFS)
Number of subjects: 100
Study 36045948 — intervention group
Group type: COMPARATOR
Intervention: Plate fixation (Control)
Number of subjects: 100
Study 34187478 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically mimicking statins
Number of subjects: 1701
Study 34187478 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically mimicking PCSK9 inhibitors or ezetimibe
Number of subjects: 1701
Study 34187478 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically higher LDL-c
Number of subjects: 1701
Study 33548944 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable hemostatic powder
Number of subjects: 21
Study 33548944 — intervention group
Group type: COMPARATOR
Intervention: Nasopore
Number of subjects: 21
Study 32150272 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 0
Study 32534948 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style dietary pattern (MED-diet)
Number of subjects: 23
Study 32534948 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 23
Study 35298280 — intervention group
Group type: COMPARATOR
Intervention: Three scans (6, 18, and 36 months)
Number of subjects: 669
Study 35298280 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven scans (6, 12, 18, 24, 36, 48, and 60 months)
Number of subjects: 669
Study 35298280 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI (three scans)
Number of subjects: 669
Study 35298280 — intervention group
Group type: COMPARATOR
Intervention: CT (seven scans)
Number of subjects: 669
Study 35298280 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 669
Study 35298280 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninferiority of MRI versus CT
Number of subjects: 669
Study 34482319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C and thiamine for 48 hours
Number of subjects: 97
Study 34482319 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 97
Study 34482319 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and control groups
Number of subjects: 97
Study 33191629 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous artificial gravity training on a short-arm centrifuge (30 min/day)
Number of subjects: 24
Study 33191629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent centrifugation (6 x 5 min/day)
Number of subjects: 24
Study 33191629 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 33191629 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest (all groups)
Number of subjects: 24
Study 36189794 — intervention group
Group type: EXPERIMENTAL
Intervention: MC4R agonism
Number of subjects: 31